Gold-based nanomaterials for the treatment of brain cancer

Abstract

Brain cancer, also known as intracranial cancer, is one of the most invasive and fatal cancers affecting people of all ages. Despite the great advances in medical technology, improvements in transporting drugs into brain tissue have been limited by the challenge of crossing the blood-brain barrier (BBB). Fortunately, recent endeavors using gold-based nanomaterials (GBNs) have indicated the potential of these materials to cross the BBB. Therefore, GBNs might be an attractive therapeutic strategy against brain cancer. Herein, we aim to present a comprehensive summary of current understanding of the critical effects of the physicochemical properties and surface modifications of GBNs on BBB penetration for applications in brain cancer treatment. Furthermore, the most recent GBNs and their impressive performance in precise bioimaging and efficient inhibition of brain tumors are also summarized, with an emphasis on the mechanism of their effective BBB penetration. Finally, the challenges and future outlook in using GBNs for brain cancer treatment are discussed. We hope that this review will spark researchers' interest in constructing more powerful nanoplatforms for brain disease treatment.

Potential of Lipid Based Nanodrug Carriers for Targeted Treatment of Glioblastoma: Recent Progress and Challenges Ahead

“…Although LCNs avoid renal clearance preferably within the range of 10-50 nm, but they tend to accumulate heavily in the reticulo-endothelial system (RES), which is also another major setback for their sufficient brain bioavailability. Further, LCNs like other nanodrug carriers below the size of 10 nm possess the risk of higher glomerular filtration followed by renal clearance [32,33]. All such problems are now being addressed successfully by the advanced formulation technologies, adaptation of cutting age research instruments and effective surface manipulation and employment of novel polymers (natural/synthetic).…”

Gold nanoparticles: current and upcoming biomedical applications in sensing, drug, and gene delivery

“…The readers could find excellent reviews on cancer treatment by AuNPs in the literature. [109][110][111] In 2010, Brown et al 112 reported platinum-bound AuNPs for improved cancer drug delivery, in which oxaliplatin was the active platinum component. The authors probed the cytotoxicity, drug uptake, and localization of the platinum-bound AuNPs in lung epithelial cell line A549 and colon cancer cell lines HCT116, HCT15, HT29, and RKO.…”

Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives

“…It offers multiple advantages such as ease of preparation with designed functionalities, surface modifications to achieve desired targeting, efficacy improvement through altering the pharmacokinetic profile of therapeutics and its ability to penetrate via leaky vasculature of the tumors (Sonali et al., 2018 ). As discussed earlier, blood-brain barrier (BBB) is the main hurdle in the way therapeutics enter the brain that ultimately leads to therapy failure (Tu et al., 2021 ). Luckily, nanocarriers especially gold-based and polymers-based nano-materials (GBNs) have solved that issue which loading therapeutic substances and delivering them to specific brain tissues with enhanced stability, solubility, and reduced side effects (Beik et al., 2019 ).…”